Many consumer groups feel that the Country A drug approval process too easy and

Question

Many consumer groups feel that the Country A drug approval process too easy and as a result, too many drugs are approved that are later found to be unsafe. On the other hand, number of industry lobbyists have pushed for a more lenient approval process so that pharmaceutical companies can get new drugs approved more easily and quickly. Consider a null hypothesis that a new, unapproved drug is unsafe and an alternative hypothesis that approved drug is safe. Complete parts (a) through (d) below. a. Explain the risks of committing a Type I or Type Il error. Choose the correct answer below. A. A Type I error would be incorrectly failing to approve an unsafe drug. A Type Il error would be incorrectly approving a safe drug. B. A Type l error would be incorrectly approving a safe drug. A Type II error would be incorrectly failing to approve an unsafe drug. C. A Type I error would be incorrectly failing to approve a safe drug. A Type I error would be incorrectly approving an unsafe drug D. A Type I error would be incorrectly approving an unsafe drug. A Type II error would be incorrectly failing to approve a safe drug. b. Which type of error are the consumer groups trying to avoid? Explain. Choose the correct the answer below. A. The consumer groups are trying to avoid a Type II error because they think that too many safe drugs a unapproved. B. The consumer groups are trying to avoid a Type I error because they think that too many safe dugs are unapproved C. The consumer groups are trying to avoid Type l error because they think that too many unsafe drugs are approved D. The consumer groups are trying to avoid a Type II error because they think that too many unsafe drugs are approved c. Which type of error are the industry lobbyists trying to avoid? Explain Choose the correct answer below. A. The industry lobbyists are trying avoid a Type II error because they think that the process of approving safe drugs is hard he B. The industry lobbyists are trying to avoid a Type I error because they think that the process of approving safe drugs is hard C. The industry lobbyists are trying to avoid a Type II error because they think that the process or approving safe drugs is too easy. D. The industry lobbyists are trying to avoid a Type I error because they think that the process of sale drugs is too easy.

Explanation / Answer

Let me first explain the meaning of Type I and Type II errors

Type I error : If we reject null hypothesis but in real it is true then type I error occur

Type II error: If we fail to reject null hypothesis but in actual null hypothesis is not true that is alternative hypothesis is true

Here the given null hypothesis is that new unapprove drug is unsafe and alternative hypothesis is the new unapproved drug is safe

So type I error is the incorrectly accept the new unapproved drug is safe that is approve drug is unsafe

So answer of part a) is " D " .

b) Since many consumer groups feel that country A drug approval process is too easy that is approval drugs are safe and they want to minimize error of approval drugs are unsafe so the correct unswer is "C"

c) Industrial lobbyists want to avoid approve drug is unsafebecause they think approving safe drug in hand so answer of this part is "A"

Related Questions

Navigate

• Browse (All)
• Browse M
• Subjects

---

---

Integrity-first tutoring: explanations and feedback only — we do not complete graded work. Learn more.